Having trouble accessing articles? Reset your cache.

Ginkgo invests $80M in Synlogic as partners collaborate on synthetic microbe development

Encouraged by a previous pilot collaboration, Ginkgo will invest $80 million in Synlogic and use its automated cell programming platform to accelerate the development of the latter's pipeline of synthetic microbes.

For their initial partnership in 2017, Synlogic Inc. (NASDAQ:SYBX) had

Read the full 409 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers